21. DAVID MASLOVE ♂
Information acquired: 2025
DAVID MASLOVE is an academic who published a paper in 2018 entitled Prevention of nosocomial infections in critically ill patients with lactoferrin (PREVAIL study): stu. DAVID MASLOVE published this work as part of a team: Muscedere, John. Here is a description of this work: Background: Nosocomial infections remain an important source of morbidity, mortality, and increased health care costs in hospitalized patients. This is particularly problematic in intensive care units (ICUs) because of increased patient vulnerability due to the underlying severity of illness and increased susceptibility from utilization of invasive therapeutic and monitoring devices. Lactoferrin (LF) and the products of its breakdown have multiple biological effects, which make its utilization of interest for the prevention of nosocomial infections in the critically ill. Methods/design: This is a phase II randomized, multicenter, double-blinded trial to determine the effect of LF on antibiotic-free days in mechanically ventilated, critically ill, adult patients in the ICU. Eligible, consenting patients.